Drug class
Interleukin-17 Receptor A Antagonist; Antibodies, Monoclonal
Mechanism of action
Interleukin 17 Receptor A Antagonists [MoA]
General use cases
- Psoriasis
- moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
